Sanofi Expands Collaboration with Scribe Therapeutics for CRISPR-Based Therapies

Small Enzymes, Giant Leaps: CRISPR’s Next-Generation Approach to Genetic Diseases

Sanofi has expanded its collaboration with Scribe Therapeutics to advance in vivo medicines for sickle cell and other genomic diseases. This partnership, initially established in 2022 for CRISPR-based ex vivo cell therapies, has now been extended to include a second target, reflecting Sanofi's commitment to genetic disease treatments through innovative gene editing technologies.

Sanofi

Sanofi is a global healthcare and pharmaceutical company that focuses on advancing healthcare, developing innovative medicines and vaccines, and improving people's health and quality of life. The company is self-described as innovative in its approach to research and development.

Medley

Sanofi Pasteur MSD

Sanofi Polska

Sanofi Belgium

Shantha Biotechnics Limited,Part of Sanofi Aventis Group

Chattem, Inc.

Foundation S

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. 

Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

BioNTech

Warp Drive Bio

Provention Bio

Melinta Therapeutics

Regulus Therapeutics

Gyroscope Therapeutics

Icosavax

Exscientia

Fulcrum Therapeutics

MyoKardia

Nereus Pharmaceuticals

Innovent Biologics

Eden Biologics

Evotec

Blackstone Life Sciences

Merci Paris 2024 ✨
Merci Team Sanofi 💜
Merci Sanofi Volunteers 🫶

What an unforgettable experience these Games have been! We showed the world how science and sport are so closely connected. It’s all about the determination and resilience that bring us together. 💜

#WeNeverSettle #IgnitingPotential #TeamSanofi #Paris2024 #Paralympics
Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

👉 We’re taking you through the streets of Paris during the #Paris2024 Paralympic Games, zooming in on the #MeningitisFlag campaign displayed at the Franklin D. Roosevelt metro station. 

With the Games lighting up Paris, this is an experience in its own right: one dedicated to the fight against meningitis, featuring para-athletes Ellie Challis, Theo Curin, and Davide Morana proudly flying the #MeningitisFlag. 💛💜💙

Participate from where you stand and click here to raise their score: http://spkl.io/6041fBtbD 

#DefeatMeningitis #ParalympicGames
Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024 
Meningitis Research Foundation

Team Sanofi is back, taking over Paris once again!  ✨ 
 
Discover the inspiring stories of our #TeamSanofi athletes & Sanofi scientists! See how their friends, loved ones, and mentors supported and encouraged them to never settle in their pursuit of dreams. 

Missed it in Paris? Catch up and learn more here: https://lnkd.in/dTWPBpMb

#IgnitingPotential #WeNeverSettle #Paris2024 #Paralympics
Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

Our #volunteers are bringing incredible energy to the #Paralympics! Thanks for bringing out the magic of the Games and making them unforgettable! We couldn’t be prouder of our amazing Sanofians 💜✨
#Paris2024 #IgnitingPotential #WeNeverSettle

New positive Phase 3 results on our BTKi for people living with non-relapsing secondary progressive #MultipleSclerosis. These results have the potential to provide a new treatment for those who have no options. Update on relapsing MS results. 

To learn more, read our press release: https://lnkd.in/etvySDp5

Explore the story of the #MeningitisFlag campaign in Paris, from idea 💡to execution 🖼️

🏅 During the #Paris2024 Paralympic Games, Ellie Challis, Theo Curin and Davide Morana picked their side, the one in the fight against #meningitis.  

📣 And now it’s time to pick your side. 

Let’s fly the Meningitis Flag together. Show your support by commenting: 💛💜💙 

Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024 

Meningitis Research Foundation 

#DefeatMeningitis

Ready, set, GO! The #Paris2024 #Paralympic Games are here! 

We’re off to a strong start with our Team Sanofi Athlete Nantenin KEITA lighting up the Opening Ceremony as a flag bearer and torchbearer, following her iconic relay with the Olympic Flame Paris 2024! 🌟 

Our volunteers are ready to bring the Games to life, and all Sanofians are geared up to cheer on our #TeamSanofi athletes.  

You’ve got this, Lauren Rowles, Ezra Frech, Ellie Challis, and Nantenin Keita! ✨ 

Last but not least, let’s make a difference by flying the #MeningitisFlag high during these Games!  💛💜💙 

#IgnitingPotential #WeNeverSettle #Paralympics #OpeningCeremony 
Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

The past 24 hours have been nothing short of ✨MAGICAL✨—and this is just the beginning! Here are the highlights👇 
 
🐎 Our iconic Metal Horse from the Olympic Games Paris 2024 Opening Ceremony is now proudly showcased at the mayor’s office in Paris. 
 
✨ Our extraordinary Sanofi volunteers have traveled across the globe, ringing in plenty of energy and motivation, for a kick-off at the UNESCO House in Paris!   
 
🔥 The #Paris2024 Paralympic Flame stopped at La Maison Sanofi! Our CEO Paul Hudson and our Executive VP Corporate Affairs Audrey Duval proudly carried the Flame to our HQ where ecstatic Sanofians cheered them on! 
 
#Paralympics #Paris2024 
Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

The Torch Relay is back, and this time, for the Paris 2024 Paralympic Games! To keep the excitement going, we’re showcasing more stories from our very own Sanofi Torchbearers 🔥💜 

Meet Rafik Amrane, former Olympic Rower and Paris 2024 Olympic Torchbearer. Like Olympic and Paralympic athletes, we’re always pushing the limits of what’s possible. For us, that means chasing the miracles of science! 

We’re proud that 42 Sanofi employees are carrying the Paris 2024 Paralympic Flame across 24 cities. This journey will end on a high note for us, with the Flame stopping at our Paris HQ!  

#IgnitingPotential #Paralympics #Paris2024 

Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

Each Sanofian plays an important role in chasing the miracles of science to improve people’s lives ✨ 

Samantha, a Site Quality Operations Manager in the US, who was also a volunteer for the #Paris2024 Olympic Games, appreciates how her colleagues bring their backgrounds and experiences together to reach a common goal. 

Her role has given her more courage and confidence to never settle, even outside of work.

Learn more about how we’re working together to build a healthier, more resilient world: http://spkl.io/6049f6ZTN 

#WeNeverSettle

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

COM:SANOFI

Sanofi

Last Close

90.87

22/11 16:39

Market Cap

118.54B

Beta: -

Volume Today

1.67M

Avg: -

Analysis Not Available